Wolfe Research Adjusts HCA Healthcare Price Target to $400 From $358, Maintains Outperform Rating
HCA Healthcare Analyst Ratings
RBC Capital Maintains HCA Healthcare(HCA.US) With Buy Rating, Raises Target Price to $405
RBC Capital Reaffirms Their Buy Rating on HCA Healthcare (HCA)
BofA Securities Maintains HCA Healthcare(HCA.US) With Buy Rating
Bank of America Securities Remains a Buy on HCA Healthcare (HCA)
Cantor Fitzgerald Reiterates Overweight on HCA Healthcare, Maintains $392 Price Target
HCA Healthcare Analyst Ratings
Truist Financial Maintains HCA Healthcare(HCA.US) With Buy Rating, Raises Target Price to $430
Analysts Are Bullish on These Healthcare Stocks: Progyny (PGNY), HCA Healthcare (HCA)
Truist Adjusts Price Target on HCA Healthcare to $430 From $390, Maintains Buy Rating
HCA Healthcare Analyst Ratings
HCA Healthcare (HCA) Gets a Hold From J.P. Morgan
Argus Research Maintains HCA Healthcare(HCA.US) With Buy Rating
HCA Healthcare Price Target Raised to $365.00/Share From $315.00 by Wells Fargo
HCA Healthcare Analyst Ratings
Wells Fargo Maintains HCA Healthcare(HCA.US) With Hold Rating, Raises Target Price to $365
Wells Fargo Keeps Their Hold Rating on HCA Healthcare (HCA)
Goldman Sachs Adjusts Price Target on HCA Healthcare to $360 From $340
HCA Healthcare Price Target Raised to $392.00/Share From $335.00 by Cantor Fitzgerald